Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China Pharmaceutical Investing
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies Genetics Investing
Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma Pharmaceutical Investing
Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery Pharmaceutical Investing
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
pSivida Announces FDA Acceptance For Filing of New Drug Application for Durasert Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
